Insider · CIK 0001553179
Waage Christian
directorofficer
Files at HRTX (HERON THERAPEUTICS, INC. /DE/), GOSS (Gossamer Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -506,250 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -440,000 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -375,000 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -125,000 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -157,500 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -157,500 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -126,667 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -47,667 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,000 | - | - | 0 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +506,250 | - | - | 506,250 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +440,000 | - | - | 440,000 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +375,000 | - | - | 375,000 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | - | - | 125,000 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +157,500 | - | - | 157,500 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +157,500 | - | - | 157,500 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +126,667 | - | - | 126,667 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +60,000 | - | - | 60,000 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +47,667 | - | - | 47,667 | Mar 20, 2026 |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +70,000 | - | - | 70,000 | Mar 20, 2026 |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +53,960 | $0.00 | $0 | 53,960 | Feb 3, 2026 |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Common Stock | +84,500 | $0.00 | $0 | 814,061 | Jan 5, 2026 |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +506,250 | $0.00 | $0 | 506,250 | Jan 5, 2026 |
| Oct 1, 2025 | GOSS Gossamer Bio, Inc. | AGrant or award Common Stock | +125,000 | $0.00 | $0 | 710,934 | Oct 2, 2025 |
| Mar 4, 2025 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +440,000 | $0.00 | $0 | 440,000 | Mar 6, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +17,950 | $0.00 | $0 | 84,130 | Feb 3, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Stock Option (Right to Buy)derivative | +35,900 | $1.73 | $62k | 35,900 | Feb 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.